Lv2
200 积分 2024-07-23 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
11个月前
已完结
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapy
1年前
已完结
De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells
1年前
已完结
De novo design and structure of a peptide–centric TCR mimic binding module
1年前
已完结
Design of high specificity binders for peptide-MHC-I complexes
1年前
已完结
IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
1年前
已完结
Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer
1年前
已完结
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
1年前
已完结
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
1年前
已完结
Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma
1年前
已完结
皖公网安备34019202002308
